These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22926146)

  • 1. In vivo efficacy studies of layer-by-layer nano-matrix bearing kaempferol for the conditions of osteoporosis: a study in ovariectomized rat model.
    Kumar A; Gupta GK; Khedgikar V; Gautam J; Kushwaha P; Changkija B; Nagar GK; Gupta V; Verma A; Dwivedi AK; Chattopadhyay N; Mishra PR; Trivedi R
    Eur J Pharm Biopharm; 2012 Nov; 82(3):508-17. PubMed ID: 22926146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteogenic efficacy enhancement of kaempferol through an engineered layer-by-layer matrix: a study in ovariectomized rats.
    Gupta GK; Kumar A; Khedgikar V; Kushwaha P; Gautam J; Nagar GK; Gupta V; Verma A; Dwivedi AK; Misra A; Trivedi R; Mishra PR
    Nanomedicine (Lond); 2013 May; 8(5):757-71. PubMed ID: 23311987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats.
    Trivedi R; Kumar S; Kumar A; Siddiqui JA; Swarnkar G; Gupta V; Kendurker A; Dwivedi AK; Romero JR; Chattopadhyay N
    Mol Cell Endocrinol; 2008 Jul; 289(1-2):85-93. PubMed ID: 18400372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
    Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
    Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent Fugu parathyroid hormone 1 (1-34) is an anabolic bone agent in young male rats and osteopenic ovariectomized rats.
    McManus JF; Davey RA; Maclean HE; Doust EA; Chiu WS; Sims NA; Bouxsein ML; Glatt V; Zajac JD; Danks JA
    Bone; 2008 Jun; 42(6):1164-74. PubMed ID: 18387351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
    Fisher JE; Scott K; Wei N; Zhao JZ; Cusick T; Tijerina M; Karanam B; Duong L; Glantschnig H
    Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formononetin reverses established osteopenia in adult ovariectomized rats.
    Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
    Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW; Liang XG; Birchman R; Wu DD; Dempster DW; Lindsay R; Shen V
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary flavonoid kaempferol inhibits glucocorticoid-induced bone loss by promoting osteoblast survival.
    Adhikary S; Choudhary D; Ahmad N; Karvande A; Kumar A; Banala VT; Mishra PR; Trivedi R
    Nutrition; 2018 Sep; 53():64-76. PubMed ID: 29655780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT; Chan C; Müller K
    J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone-related protein 1-36, and SDZ-parathyroid hormone 893.
    Stewart AF; Cain RL; Burr DB; Jacob D; Turner CH; Hock JM
    J Bone Miner Res; 2000 Aug; 15(8):1517-25. PubMed ID: 10934650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y; Won YY; Baek MH; Lim SK
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dried plum reverses bone loss in an osteopenic rat model of osteoporosis.
    Deyhim F; Stoecker BJ; Brusewitz GH; Devareddy L; Arjmandi BH
    Menopause; 2005; 12(6):755-62. PubMed ID: 16278620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.